arrow
S

Scott D. Sagel

University of Colorado System
H指数:52
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Longitudinal changes in bone mineral density after initiation of elexacaftor-tezacaftor-ivacaftor in youth and adults with cystic fibrosis: PROMISE-ENDO

在患有囊性纤维化的青年和成人中,elexacaftor-tezacaftor-ivacaftor开始后骨矿物质密度的纵向变化: PROMISE-ENDO

2026-01-300
OAAI
Airway Disease Progression on Chest Computed Tomography in Children With Primary Ciliary Dyskinesia

儿童原发性纤毛运动障碍患者胸部计算机断层扫描中的气道病变进展

2025-09-180
PRE
Overlapping Clinical Phenotypes in Patients with Primary Ciliary Dyskinesia or Activated Phosphoinositide 3-Kinase Delta Syndrome
2025-05-010
PRE
Changing Epidemiology of Pediatric Pulmonary Exacerbations in Cystic Fibrosis

囊性纤维化患儿肺病恶化的流行病学变化

2025-02-280
OA
Glycemia and Insulin Secretion in Cystic Fibrosis 2 Years After Elexacaftor/Tezacaftor/Ivacaftor: PROMISE-ENDO
2024-12-091
OA
Situs Ambiguus Is Associated With Adverse Clinical Outcomes in Children With Primary Ciliary Dyskinesia

Situs歧义与原发性睫状运动障碍儿童的不良临床结局相关

CHEST
IF8.6
2024-05-011
PRE
Prospective evaluation of nontuberculous mycobacteria disease in cystic fibrosis: The design of the PREDICT study
2024-01-014
OAAI
Airway Disease in Children with Primary Ciliary Dyskinesia Impact of Ciliary Ultrastructure Defect and Genotype
2023-04-0113
PRE
Elexacaftor/tezacaftor/ivacaftor and gastrointestinal outcomes in cystic fibrosis: Report of promise-GI
2023-03-0152
OAAI